(MENAFN- GlobeNewsWire - Nasdaq) The Clinical Trial Supply and Logistics Market presents strong growth opportunities from 2025-2035, driven by the need for resilient, efficient supply chains amidst geopolitical and tariff challenges. Key opportunities lie in localizing supply chains, investing in regional hubs, and enhancing logistics to ensure trial integrity and operational efficiency.

Dublin, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trial Supply and Logistics Market for Pharma 2025-2035" has been added to ResearchAndMarkets's offering.
World revenue for the Clinical Trial Supply and Logistics Market for Pharma is set to surpass US$16 billion in 2025, with strong revenue growth through to 2035.
Supply Chain Disruptions Pose Market Challenges
Global supply chains remain highly vulnerable to shocks, whether from pandemics, geopolitical conflicts, or raw material shortages. Rising air freight costs, port congestion, and customs delays disrupt timelines and jeopardise trial integrity. These challenges are pushing sponsors to partner with logistics providers that can offer diversified transport options, strategically located regional depots, and robust contingency planning. Providers unable to guarantee business continuity risk both reputational damage and commercial losses. As a result, resilience and redundancy have become critical differentiators in partner selection, reshaping the competitive dynamics of the clinical trial supply and logistics (CTSL) market.
Impact of US Trade Tariffs on the Global Clinical Trial Supply and Logistics for Pharma Market
The imposition of U.S. trade tariffs is expected to create ripple effects across the global clinical trial supply and logistics (CTSL) market, particularly as companies dependent on cross-border movement of trial materials face mounting operational costs. Increased tariffs on imported APIs, packaging materials, and specialised equipment can slow procurement processes and tighten budgets, especially for trials that rely on just-in-time delivery models. This environment of heightened uncertainty risks delaying clinical milestones and extending development timelines for new therapies.
Beyond the immediate financial impact, tariffs are likely to influence long-term strategic decisions. Pharmaceutical sponsors and logistics providers may increasingly localise supply chains, invest in regional distribution hubs, or establish tariff-free trade routes to safeguard competitiveness. However, smaller firms with limited resources could struggle to absorb additional costs, widening the gap between global players and niche service providers. In this way, U.S. tariffs not only add pressure to the cost base of trial logistics but also redefine the competitive landscape of the industry.

Forecasts to 2035 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2035, the new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

Type

• CTS Manufacturing
• CTS Logistics & Distribution
• CT Supply Chain Management
• CTS Packaging & Storage

Phase

• Preclinical
• Phase I
• Phase II
• Phase III
• Phase IV
• Post Launch

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 26 leading national markets.

The report also includes profiles for some of the leading companies in the Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035, with a focus on this segment of these companies' operations.
Leading companies and the potential for market growth

• Almac Group
• Bilcare Limited
• Biocair
• Catalent, Inc.
• COREX Logistics
• Eurofins Scientific
• FedEx
• ICON plc
• Intertek Group plc
• Kerry Logistics Network Limited
• Kuehne+Nagel
• Marken (A UPS Company)
• Mayne Pharma Group Limited
• Movianto
• NAF Pharma
• Oximio
• Parexel International Corporation
• PCI Pharma Services (PCI)
• Royal Cargo
• Thermo Fisher Scientific Inc.
• United Parcel Service, Inc.
• Yourway

How will the Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035 report help you?
In summary, the report provides you with the following knowledge:

• Revenue forecasts to 2035, with forecasts for type and phase, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2035 for five regional and 26 key national markets, among other prominent economies.
• Prospects for established firms and those seeking to enter the market - including company profiles for 25 of the major companies involved in the Clinical Trial Supply and Logistics for Pharma Market.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN15102025004107003653ID1110200726